Guilherme Perboyre Cavalcanti
Analyst · JPMorgan
Thank you, Tomazoni. Let's now move on to the operational and financial highlights of the second quarter of 2025, starting on Slide 13, please. Net revenue for the second quarter 2025 reached a record of $21 billion. Adjusted EBITDA totaled $1.8 billion, which represents a margin of 8.4% in the quarter, while adjusted operating income was $1.2 billion with a margin of 5.7%. Net profit was $528 million in the quarter and earnings per share was $0.48 per share. Excluding the nonrecurring item, adjusted net income would be $583 million and the EPS would be $0.53. Finally, the return on equity was 25.7% and the return on invested capital was 17%. Although the difference in EBITDA between the second quarter 2024 and the second quarter 2025 was only $141 million, the free cash flow difference reached approximately $1.1 billion due mainly to the following factors. The difference in EBITDA, as mentioned above, $104 million of higher capital expenditures, $242 million increase in finished goods inventories in the U.S. driven by higher prices. This cash is expected to return to the operating results over the coming quarters as sales are made. $250 million due to livestock hedging. Future purchase from suppliers such as feedlots at fixed prices are hedged through future contracts, exposing us to the spot price and thus matching with the mid sales. Due to the sharp rise in the cattle and hog prices, there was a negative cash impact on operating results due to the hedge. This cash is expected to return in the following quarters as the physical purchases are settled. $122 million increase in legal settlements, $257 million in higher tax payments, mainly due to improved results from PVC and Australia in recent quarters. $51 million impact on Seara's chicken inventory caused by the market closure due to a single -- it should return to around $4.5 billion based on the following estimated breakdowns, which may change over time due to the variables beyond our control. So capital expenditures of $2 billion in 2025 and $2 billion in 2026, which already included maintenance CapEx. Working capital of $900 million in 2025 and $250 million in 2026. The additional $650 million in 2025 compared to 2026 is due to the inventory and hedging tax explained earlier. Legal settlements of $300 million in 2025 and assuming 0 in 2026. Biological assets of $650 million in 2025 and the same amount for 2026. Interest expenses of $1.15 billion in 2025 and $1.1 billion in 2026. Leasing expenses of $500 million in 2025 and repeating in 2026. Moving on to Slide 16 to discuss our debt position and leverage. In June, we accessed the bond market to refinance our short-term and 2027 and 2028 and 2030 maturities. Strong investor demand allowed us to upsize the issuance to $3.5 billion while achieving a record low spreads for issuers with our credit ratings, which includes a $1 billion 40-year tranche. In addition, Seara issued approximately $160 million in local debentures. We used $3 billion to efficiently retire debt, creating nearly all maturities through 2031. As a result, our average maturity extended from 11 to 15 years, while the average cost increased by just 25 basis points to 5.6%. We kept the 2029 bond outstanding given its low 3% coupon, along with the 2031 bond at 3.75% and 2022 notes with coupons of 3.625% and 3%. From the $3.5 billion raised, $500 million was retained as excess cash. Leverage increased to 2.27x in the second quarter 2025, primarily due to $141 million decline in last 12-month EBITDA and the payment of $1.5 billion in dividends. Interest coverage remained stable at 7.7x compared to the previous quarter. With leverage at the lower end of our comfort range, stable interest coverage in line with recent quarters, no significant debt amortization in the coming years and a strong cash position, we announced a share buyback program of up to $400 million. We believe this represents an efficient use of excess cash given the current valuation multiples relative to our global peers. The repurchase programs may be implemented through open market purchase, privately negotiated transactions or under Rule 10b5-1 of the Exchange Act. Even with the share buyback program, we expect to end the year with leverage below 2.5x and interest coverage consistent with the end of 2024 levels at 7.4x. Our $3.4 billion in revolving credit lines and available cash of $3 billion, combined with expected cash generation in the second half, provide a robust financial position to continue pursuing value creation opportunities to our shareholders. I'll now briefly go through the business units. Starting with Seara on Slide 20. During the second quarter -- in the first half of the quarter, we saw a favorable commercial environment, both in the domestic and export markets. However, in mid-May, Brazil reported its first case of avian flu in a commercial flock. The country was officially declared free of the disease again in June, but some key export markets remain temporarily closed, which affected commercial performance. Even with the temporary headwinds caused by the outbreak, Seara achieved an adjusted EBITDA margin of 18.1% in the quarter, reflecting our strong focus, agility and discipline in pursuing operational and commercial excellence. Moving on to Slide 21. In the second quarter of 2025, JBS Brazil recorded net revenue of 20% higher than in the second quarter 2024 driven by strong demand in both international and domestic markets, which partially offset the sharp increase in cattle prices. As a result, the EBITDA margin reached 6.4% in the quarter. Moving on to Slide 22. And now speaking in dollars and under U.S. GAAP, JBS Beef North America net revenue in the second quarter grew 14% year-over-year driven by strong demand, and that drove cutout values to record levels in the U.S. However, profitability continues to be pressured by the challenging cattle cycle, which has also kept live cattle prices at record highs as well as by the additional headwinds related to global trade and animal health concerns in Mexico. On Slide 23, we have JBS Australia. In the annual comparison, the 20% revenue growth was primarily driven by higher volumes of beef exports. The EBITDA margin reached 12.7% and increasing 50 basis points compared to the same period last year, reflecting great availability of animals for slaughter and gains in operational efficiency. Turning now to JBS USA. Pork net revenues for the quarter decreased by 5% year-over-year. The pork business was affected on a short-term basis by trade restrictions, but the expected performance to return to normal levels over the next few quarters. Pilgrim's Pride, as highlighted on Slide 25, reported a 4% increase in net revenue in the quarter. In the second quarter 2025, Pilgrim's delivered record adjusted EBITDA of $687 million. In addition to a favorable commercial environment across its key markets, the strong performance reflects the successful execution of its strategy, including the strengthening partnership with the customers' expansion of value-added and branded products, innovation and efficiency gains. With that in mind, I would like to open for Q&A session.